Trial Profile
Effect of inhaled vilanterol trifenatate/fluticasone furoate on length tension relation of the diaphragm in severe chronic obstructive pulmonary disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Nov 2017
Price :
$35
*
At a glance
- Drugs Vilanterol/fluticasone furoate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 13 Nov 2017 New trial record